Neurol. praxi. 2009;10(5):285-289

Basic cerebrospinal fluid test in diagnosing central nervous system involvement

RNDr. Ing. Petr Kelbich1, doc. MUDr. Pavel Adam, CSc2, MUDr. Ondřej Sobek, CSc2, MUDr. Martina Koudelková2, MUDr. Jan Procházka3, Eva Hanuljaková4, MUDr. Radka Válková5, MUDr. Miloslav Tomaškovič5, Mgr. Martin Krušina1
1 Oddělení klinické biochemie, hematologie a imunologie Nemocnice Kadaň s.r.o., Kadaň
2 Laboratoř pro likvorologii a neuroimunologii - Toplex, s.r.o., expertní pracoviště SEKK, ÚVN Praha
3 Oddělení intenzivní medicíny, Krajská zdravotní, a.s. - Masarykova nemocnice v Ústí nad Labem, o.z
4 Oddělení klinické biochemie, Krajská zdravotní, a.s. - Nemocnice Most, o.z
5 Infekční oddělení, Masarykova nemocnice, Ústí nad Labem

Every laboratory test of biological material, including the cerebrospinal fluid, should follow a logical sequence. It should proceed from

simple to complex and from general to specific. Basic cerebrospinal fluid test which the paper deals with is usually at the very beginning of

this procedure. The aim of the paper is not only to present the reader with a list of the parameters followed, but mainly to attempt at clearly

clarifying their significance for disclosing the nature of some pathological processes taking place in the central nervous system (CNS).

Keywords: cerebrospinal fluid compartment, blood-cerebrospinal fluid barrier, energetic conditions, cerebrospinal fluid cytology, CNS inflammation.

Published: December 1, 2009  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kelbich P, Adam P, Sobek O, Koudelková M, Procházka J, Hanuljaková E, et al.. Basic cerebrospinal fluid test in diagnosing central nervous system involvement. Neurol. praxi. 2009;10(5):285-289.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Adam P. Cytologie likvoru. 1st ed. Pardubice, Stapro, 1995.
    2. Adam P, Táborský L, Sobek O, Hildebrand T, Kelbich P, Průcha M, Hyánek J. Cerebrospinal Fluid. Advances in Clinical Chemistry. Academic Press, San Diego, San Francisco, New York, Boston, London, Sydney, Tokyo 2001: 1-62. Go to original source... Go to PubMed...
    3. Adam P, Táborský L, Sobek O, Kelbich P, Průcha M. Proteinologie mozkomíšního moku. 1st ed. Praha, Medica News Publishers, 2002. Go to original source...
    4. Adam P, Votruba M, Hrbková M, Sobek O, Turek S. The Scavanger Effect of Albumin in CSF of Patients with Damaged Blood Brain Barrier (The big albumin story-part two). Klin Biochem Metab 2002; 10(31): 122-125.
    5. Adam P, Táborský L, Sobek O, Kelbich P. Cytology of Cerebrospinal Fluid. 1st ed. Praha, Medica News Publishers, 2003. Go to original source...
    6. Felgenhauer K. Laboratory Diagnosis of Neurological Diseases. In Thomas L (ed.): Clinical Laboratory Diagnostics. Use and Assessment of Clinical Laboratory Results. Frankfurt/ Main, TH-Books Verlagsgesellschaft mbH, 1998: 1308-1326.
    7. Gloor SM, Wachtel M, Bolliger MF, Ishikara H, Landmann R, Frei K. Molecular and cellular permeability control at the blood-brain barrier. Brain Research Reviews 2001; 36: 258-264. Go to original source... Go to PubMed...
    8. Hořejší V, Bartůňková J. Základy imunologie. 3rd ed. Praha, Triton, 2005.
    9. Karlson P. Základy biochemie. 3rd ed. Praha, Academia, 1981.
    10. Kelbich P, Slavík S, Jasanská J, Adam P, Hanuljaková E, Jermanová K, Řepková E, Šimečková M, Procházková J, Gajdošová R, Sobek O, Zeman D, Nekola P. Hodnocení energetických poměrů v likvorovém kompartmentu pomocí vyšetřování vybraných parametrů metabolismu glukosy v CSF. Klin Biochem Metab. 1998; 6(27): 213-225.
    11. Kelbich P, Šimečková M, Adam P, Válková R, Hanuljaková E, Sobek O, Táborský L, Chmelíková V, Zeman D, Žáčková A. Likvorové nálezy u pacienta s bakteriální meningitidou - kazuistika. Klin Biochem Metab. 2002; 10(31): 54-68.
    12. Kelbich P, Koudelková M, Machová H, Tomaškovič M, Vachata P, Kotalíková P, Chmelíková V, Hanuljaková E. Význam urgentního vyšetření mozkomíšního moku pro včasnou diagnostiku neuroinfekcí. Klin mikrobiol inf lék 2007; 13(1): 9-20.
    13. Krejsek J, Kopecký O. Klinická imunologie. 1st ed. NUCLEUS HK, 2004.
    14. Lamers KJB, Wevers RA. Cerebrospinal Fluid Diagnostics: Biochemical and Clinical Aspects. Klin Biochem Metab 1995; 24: 63-75.
    15. Machová H, Kelbich P. Je laboratorní obraz purulentního zánětu při vyšetření likvoru v souvislosti se SAK? Abstrakt přednášky v rámci konference, ,5. den pro laboratorní aspekty likvorologie a neuroimunologie". Alergie. 2006; 8(4): 345.
    16. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunology Today 1994; 15: 81-88. Go to original source... Go to PubMed...
    17. Šterzl J. Imunitní systém a jeho fyziologické funkce. 1st ed. Praha, ČIS, 1993.
    18. Tumani H, Nau R, Felgenhauer K. ?-trace protein in cerebrospinal fluid: A blood-CSF barrier related evaluation in neurological diseases. Ann Neurol 1998; 44: 885-889. Go to original source...
    19. Volanakis JE. Human C-reactive protein: expression, structure, and function. Molecular Immunology 2001; 38: 189-197. Go to original source... Go to PubMed...
    20. Votruba M, Adam P, Hrbková M, Hroudová J, Sobek O. Mechanismus účinku volných radikálů na funkční stav hematolikvorové bariery. Klin Biochem Metab 2000; 4(8): 240-243.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.